Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. HYUNDAI BIOLAND Co.,Ltd
  6. Summary
    A052260   KR7052260007

HYUNDAI BIOLAND CO.,LTD

(A052260)
  Report
End-of-day quote Korea Stock Exchange  -  2023-01-25
13880.00 KRW   -0.93%
2020Hyundai HCN Co.,Ltd. (KOSE:A126560) completed the acquisition of 27.94% stake in SKbioland Co., Ltd. (KOSDAQ:A052260) from SKC Co., Ltd. (KOSE:A011790).
CI
2020Hyundai HCN Co.,Ltd. (KOSE:A126560) agreed to acquire 27.94% stake in SKbioland Co., Ltd. (KOSDAQ:A052260) from SKC Co., Ltd. (KOSE:A011790) for approximately KRW 120 billion.
CI
2020UCI Co.,Ltd. acquired 30.9% stake in Bio X Co., Ltd. from group of sellers for KRW 20 billion.
CI
 SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
01/18/2023 01/19/2023 01/20/2023 01/25/2023 01/26/2023 Date
13500 13950 13950 14010 13880 Last
13093 40551 42580 113598 27196 Volume
0.00% +3.33% 0.00% +0.43% -0.93% Change
Estimated financial data (e)
Sales 2020 88 899 M 72,0 M 72,0 M
Net income 2020 -13 545 M -11,0 M -11,0 M
Net Debt 2020 32 037 M 25,9 M 25,9 M
P/E ratio 2020 -27,1x
Yield 2020 0,41%
Sales 2021 103 B 83,3 M 83,3 M
Net income 2021 -11 686 M -9,46 M -9,46 M
Net Debt 2021 18 570 M 15,0 M 15,0 M
P/E ratio 2021 -22,1x
Yield 2021 0,41%
Capitalization 208 B 169 M 169 M
EV / Sales 2020 4,49x
EV / Sales 2021 2,69x
Nbr of Employees 326
Free-Float 65,0%
More Financials
Company
Hyundai Bioland Co Ltd, formerly SK Bio Land Co Ltd, is a Korea-based company mainly engaged in the development and manufacture of raw materials for cosmetics. The Company operates its business through four segments. The Cosmetic Raw Material segment produces products such as portulaca extracts, ulmus extracts, crinum extracts, hyaluronic acids and arbutins. The Pharmaceutical Ingredient segment manufactures and... 
Read more
Sector
Personal Products
Calendar
05/12Earnings Release
More about the company
All news about HYUNDAI BIOLAND CO.,LTD
2020Hyundai HCN Co.,Ltd. (KOSE:A126560) completed the acquisition..
CI
2020Hyundai HCN Co.,Ltd. (KOSE:A126560) agreed to acquire 27.94% ..
CI
2020UCI Co.,Ltd. acquired 30.9% stake in Bio X Co., Ltd. from group of sellers for KRW 20 b..
CI
2020UCI Co.,Ltd. announced that it has received KRW 20 billion in funding from Pacific Inve..
CI
2015SKC Co. Ltd. completed the acquisition of an additional 4.39% stake in Bioland Co., Ltd..
CI
2015SKC Co. Ltd. agreed to acquire an additional 4.39% stake in Bioland Co., Ltd. from Chan..
CI
2015Bioland Co., Ltd(KOSDAQ:A052260) added to Russell Global Index
CI
2014SK Holdings Co., Ltd. and Paratus the 1st Special Purpose Company LLC completed the acq..
CI
2014SK Holdings Co., Ltd. entered into a contract to acquire additional 24.31% stake in Bio..
CI
2014SKC Eyes Bioland
CI
More news
News in other languages on HYUNDAI BIOLAND CO.,LTD

- No features available -

More news
Chart HYUNDAI BIOLAND CO.,LTD
Duration : Period :
HYUNDAI BIOLAND Co.,Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Hui-Joon Lee Chief Executive Officer & Director
Hyun-Taek Oh Independent Director
Yoon-Sung Nam Independent Director
Kwang-Hyun Koh Independent Director
Kyu-Han Im Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
HYUNDAI BIOLAND CO.,LTD3.20%169
L'ORÉAL15.50%223 774
SHISEIDO COMPANY, LIMITED1.78%20 179
KAO CORPORATION-0.74%18 593
YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO.LTD-6.87%8 680
COTY INC.15.07%8 467